The resistance of Pseudomonas aeruginosa strains to fluoroquinolone group of antibiotics

Indian Journal of Medical Microbiology

Volumn 22, Issue 2, 2004, Pages 112-114

  Algun, U ^a   Arisoy, A ^a   Gunduz, T ^a   Ozbakkaloglu, B ^a  

^a CELAL BAYAR UNIVERSITY   (Turkey)

Author keywords

Fluoroquinolones; Pseudomonas aeruginosa; Resistance

Indexed keywords

CIPROFLOXACIN; LEVOFLOXACIN; NORFLOXACIN; OFLOXACIN; PEFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATION; CHI SQUARE TEST; CONTROLLED STUDY; DRUG EFFICACY; FISHER EXACT TEST; GRAM NEGATIVE BACTERIUM; INTENSIVE CARE UNIT; NONHUMAN; PSEUDOMONAS AERUGINOSA;

EID: 2442558349     PISSN: 02550857     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Erdem B. Pseudomonas. In: Ustacelebi S. Basic Clinl Microbiol. Ankara, Gunes Publication. 1999:551-558.
2. Tunger O, Aydemir S. Quinolones. Turk J Antibiotics 2000;1:18-24.
3. National Committee for Clinical Laboratory Standards. Performance Standards for Antimicrobial Disk Susceptibility Tests. NCCLS Document, 6th ed: Wayne Pa, Approved Standard M2-A5 (M100-S7) 2002.
4. Swiatlo E, Moore E, Watt J, Mc Daniel LS. In vitro activity of four floroquinolones against clinical isolates of Pseudomonas aeruginosa determined by the E test. Int J Antimicrob Agents 2000;15:73-76.
5. Hooper DC. Quinolones. In: Principles and Practice of Infectious Disease 5th ed. (Mandell, GL, Bennet, JE, Dolin, R) 2000:404-423.
6. Bouza E, Garcia-Garrotte F, Cercenato E, Marin M, Diaz MS. Pseudomonas aeruginosa: A survey of resistance in 136 hospitals in Spain. Antimicrob Agents Chemother 1999;43(4):981-982.
7. Cavallo JD, Leblanc F, Fabre R, Fourticq-Esqueoute. Survey of the antibiotic sensitivity of Pseudomonas aeruginosa in France and the distribution of beta-lactam resistance mechanism. Pathol Biol 2001;49(7):534-539.
8. Yamane N, Jones R.N, Frei R, Hoban DJ, Pignatari AC, Marco F. Levofloxacin in vitro activity. Results from an international comparative study with ofloxacin and siprofloxacin. J Chemother 1994;6(2):83-91.
9. Topkaya A, Kucukercan M, Oguzoglu N, et al. Inducible beta-lactamase production and susceptibility rates of Paeruginosa strains to aminoglicosides and quinolons. X.Turkish Microbiology and Infectious Diseases Congress Book 2001;272.
10. Prosser BLT, Beskid G. Multicenter in vitro comparative study of fluoroquinolones against 25.129 gram-positive and gram-negative clinical isolates. Diagn Microbiol Infect Dis 1995;21:33-45.
11. Kumarasingle G, Chow C, Koh BL, Chiang KL, Liew HY, Ti TY. Antimicrobial resistance problem in a university hospital. Pathology 1995;27(1):67-70.
12. Carmeli Y, Troillet N, Eliopoulos GM, Samore MH. Emergence of antibiotic-resistant Pseudomonas aeruginosa: comparison of risks associated with different antipseudomonal agents. Antimicrob Agents Chemother 1999;43(6):1379-1382.
13. Fidan N, Ozgenc O, Urbarli A. Comparison of resistance rates of P.aeruginosa isolates against various antibiotics between 1996 and 2000 J Ankem 2001;15(2):169.